New insights from a systematic review and meta-analysis on the treatment of difficult-to-treat rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
New insights from a systematic review and meta-analysis on the treatment of difficult-to-treat rheumatoid arthritis ; volume:22 ; number:1 ; day:11 ; month:10 ; year:2024 ; pages:1-2 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (11.10.2024), 1-2, 12.2024
- Creator
-
He, Xianyao
Wu, Anqi
Pang, Xianlun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05721-7
- URN
-
urn:nbn:de:101:1-2412302117484.943311937006
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- He, Xianyao
- Wu, Anqi
- Pang, Xianlun
- SpringerLink (Online service)
Other Objects (12)
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Not all geriatric cachexia is cancer – The difficult lateonset rheumatoid arthritis
Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon
Total hip arthroplasty to treat acetabular protrusions secondary to rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Not all geriatric cachexia is cancer – The difficult lateonset rheumatoid arthritis
Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon
Total hip arthroplasty to treat acetabular protrusions secondary to rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry
Not all geriatric cachexia is cancer – The difficult lateonset rheumatoid arthritis
Identification and prediction of difficult-to-treat rheumatoid arthritis patients in structured and unstructured routine care data: results from a hackathon